These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 24072826)
21. Multicentric Castleman's disease in human immunodeficiency virus infection: two case reports. Caroline Ribeiro Sales A; Romão de Souza Junior V; Iglis de Oliveira M; Azevedo Braga Albuquerque C; de Barros Campelo Júnior E; Sérgio Ramos de Araújo P J Med Case Rep; 2018 May; 12(1):117. PubMed ID: 29728131 [TBL] [Abstract][Full Text] [Related]
22. Multicentric Castleman's disease in a Ghanaian adult. Dei-Adomakoh YA; Segbefia C; Ekem I; Taylor A Ghana Med J; 2013 Jun; 47(2):92-5. PubMed ID: 23966747 [TBL] [Abstract][Full Text] [Related]
23. Idiopathic multicentric Castleman disease preceded by cutaneous plasmacytosis successfully treated by tocilizumab. Aita T; Hamaguchi S; Shimotani Y; Nakamoto Y BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33148595 [TBL] [Abstract][Full Text] [Related]
24. Successful treatment of a patient with multicentric Castleman's disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody. Kawabata H; Kotani S; Matsumura Y; Kondo T; Katsurada T; Haga H; Kadowaki N; Takaori-Kondo A Intern Med; 2013; 52(13):1503-7. PubMed ID: 23812199 [TBL] [Abstract][Full Text] [Related]
25. [Effectiveness of long term administration of humanized anti-interleukin-6 receptor antibody (tocilizumab) for multicentric Castleman's disease with pulmonary involvement]. Akahane D; Kimura Y; Sumi M; Sashida G; Gotoh A; Miyazawa K; Ohyashiki K Rinsho Ketsueki; 2006 Aug; 47(8):748-52. PubMed ID: 16986713 [TBL] [Abstract][Full Text] [Related]
26. [Dyspnoea, cough and B symptoms in a 40-year-old woman]. Wolfensberger A; Benz R; Russi EW; Tinguely M; Keller C; Gerber B Internist (Berl); 2013 Aug; 54(8):1011-5. PubMed ID: 23836253 [TBL] [Abstract][Full Text] [Related]
27. Diffuse cryptococcal pneumonia in multicentric Castleman's disease with elevated serum IgG Takiguchi J; Tomioka H; Kamei K; Kawabata Y BMJ Case Rep; 2023 Mar; 16(3):. PubMed ID: 36944440 [TBL] [Abstract][Full Text] [Related]
28. A case of tocilizumab-refractory idiopathic multicentric Castleman's disease successfully treated with sirolimus. Sumiyoshi R; Koga T; Furukawa K; Umeda M; Yamamoto K; Mori R; Kawakami A Clin Immunol; 2021 Dec; 233():108887. PubMed ID: 34798240 [TBL] [Abstract][Full Text] [Related]
29. Overlap of IgG4-related Disease and Multicentric Castleman's Disease in a Patient with Skin Lesions. Mochizuki H; Kato M; Higuchi T; Koyamada R; Arai S; Okada S; Eto H Intern Med; 2017; 56(9):1095-1099. PubMed ID: 28458319 [TBL] [Abstract][Full Text] [Related]
30. Renal thrombotic microangiopathy associated with multicentric Castleman's disease. Report of two cases. Lajoie G; Kumar S; Min KW; Silva FG Am J Surg Pathol; 1995 Sep; 19(9):1021-8. PubMed ID: 7661275 [TBL] [Abstract][Full Text] [Related]
31. Reversal of cardiomyopathy with tocilizumab in a case of HIV-negative Castleman's disease. Man L; Goudar RK Eur J Haematol; 2013 Sep; 91(3):273-276. PubMed ID: 23786462 [TBL] [Abstract][Full Text] [Related]
32. Castleman's disease arising from an intrapulmonary lymph node. Tokunaga T; Kadota Y; Utsumi T; Inoue M; Minami M; Okumura M Gen Thorac Cardiovasc Surg; 2009 Oct; 57(10):562-5. PubMed ID: 19830523 [TBL] [Abstract][Full Text] [Related]
33. Multicentric Castleman's disease presenting with multiple nodes in lungs: a case report and literature review. Sun X; Han B Int J Hematol; 2008 Oct; 88(3):278-282. PubMed ID: 18815726 [TBL] [Abstract][Full Text] [Related]
34. Disseminated cryptococcosis in a patient taking tocilizumab for Castleman's disease. Nishioka H; Takegawa H; Kamei H J Infect Chemother; 2018 Feb; 24(2):138-141. PubMed ID: 29021093 [TBL] [Abstract][Full Text] [Related]
35. Successful treatment of a mesangial proliferative glomerulonephritis with interstitial nephritis associated with Castleman's disease by an anti-interleukin-6 receptor antibody (tocilizumab). Otani N; Morishita Y; Oh I; Saito O; Takemoto F; Muto S; Kusano E Intern Med; 2012; 51(11):1375-8. PubMed ID: 22687845 [TBL] [Abstract][Full Text] [Related]
36. Tocilizumab for focal segmental glomerulosclerosis secondary to multicentric Castleman's disease. Ebisawa K; Masamoto Y; Tokushige J; Nishi H; Honda K; Hinata M; Toyama K; Nangaku M; Kurokawa M Ann Hematol; 2019 Aug; 98(8):1995-1997. PubMed ID: 30761408 [No Abstract] [Full Text] [Related]
37. Hemoglobin and C-reactive protein levels as predictive factors for long-term successful glucocorticoid treatment for multicentric Castleman's disease. Ebisawa K; Shimura A; Honda A; Masamoto Y; Nakahara F; Kurokawa M Leuk Lymphoma; 2021 Mar; 62(3):614-619. PubMed ID: 33076723 [TBL] [Abstract][Full Text] [Related]
38. Multicentric Castleman's disease in HIV infection: a systematic review of the literature. Mylona EE; Baraboutis IG; Lekakis LJ; Georgiou O; Papastamopoulos V; Skoutelis A AIDS Rev; 2008; 10(1):25-35. PubMed ID: 18385778 [TBL] [Abstract][Full Text] [Related]
39. TAFRO syndrome with fatigue and abdominal distension as the first symptom: A case report. Zhou B; Tang C; Chen G; Jiang T; Shi X; Wang F Hematol Oncol; 2023 Apr; 41(2):285-290. PubMed ID: 34997628 [TBL] [Abstract][Full Text] [Related]
40. A case of TAFRO syndrome, a variant of multicentric Castleman's disease, successfully treated with corticosteroid and cyclosporine A. Takasawa N; Sekiguchi Y; Takahashi T; Muryoi A; Satoh J; Sasaki T Mod Rheumatol; 2019 Jan; 29(1):198-202. PubMed ID: 27413814 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]